INTERNATIONAL PATENT: DIANTHUS THERAPEUTICS OPCO, INC., WUXI BIOLOGICS (SHANGHAI FX) CO., LTD. FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITIONS COMPRISING ANTIBODIES FOR TREATMENT OF C1S MEDIATED DISORDERS AND METHODS OF USING THE SAME"

GENEVA, June 29 -- DIANTHUS THERAPEUTICS OPCO, INC. (7 Times Square, FL 43, Suite 4303New York, NY 10036), WUXI BIOLOGICS (SHANGHAI FX) CO., LTD. (Room 2481, Building 11150 Lanfeng Road, Fengxian DistrictShanghai 201400) filed a patent application (PCT/CN2023/140449) for "PHARMACEUTICAL COMPOSITIONS COMPRISING ANTIBODIES FOR TREATMENT OF C1S MEDIATED DISORDERS AND METHODS OF USING THE SAME" on Dec 20, 2023. With publication no. WO/2025/129535, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHEN, Taotao (7 Times Square, F...